June 5, 2020 / 1:57 PM / a month ago

BRIEF-Genscript Biotech Updates On Separate Listing Of Legend Biotech Corp On Nasdaq Global Market

June 5 (Reuters) - Genscript Biotech Corp:

* UPDATES ON PROPOSED SPIN-OFF & SEPARATE LISTING OF LEGEND BIOTECH CORP ON NASDAQ GLOBAL MARKET

* TRADING IN ADSS OF LEGEND BIOTECH TO COMMENCE ON 5 JUNE

* LEGEND BIOTECH’S INITIAL PUBLIC OFFER PRICE WAS FIXED AT US$23.00 PER ADS

* EACH ADS WILL REPRESENT 2 LEGEND BIOTECH SHARES

* 18.4 MILLION ADSS WILL BE ISSUED BY LEGEND BIOTECH REPRESENTING ABOUT 12.7% OF ITS ISSUED SHARE CAPITAL Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below